🇺🇸 FDA
Patent

US 11903970

Device and methods for platelet lysis or activation

granted A61KA61K35/19A61K45/06

Quick answer

US patent 11903970 (Device and methods for platelet lysis or activation) held by Regenexx, LLC expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regenexx, LLC
Grant date
Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K35/19, A61K45/06